Literature DB >> 20926388

Characterization of FdmV as an amide synthetase for fredericamycin A biosynthesis in Streptomyces griseus ATCC 43944.

Yihua Chen1, Evelyn Wendt-Pienkowski, Jianhua Ju, Shuangjun Lin, Scott R Rajski, Ben Shen.   

Abstract

Fredericamycin (FDM) A is a pentadecaketide natural product that features an amide linkage. Analysis of the fdm cluster from Streptomyces griseus ATCC 43944, however, failed to reveal genes encoding the types of amide synthetases commonly seen in natural product biosynthesis. Here, we report in vivo and in vitro characterizations of FdmV, an asparagine synthetase (AS) B-like protein, as an amide synthetase that catalyzes the amide bond formation in FDM A biosynthesis. This is supported by the findings that (i) inactivation of fdmV in vivo afforded the ΔfdmV mutant strain SB4027 that abolished FDM A and FDM E production but accumulated FDM C, a biosynthetic intermediate devoid of the characteristic amide linkage; (ii) FdmV in vitro catalyzes conversion of FDM C to FDM B, a known intermediate for FDM A biosynthesis (apparent K(m) = 162 ± 67 μM and k(cat) = 0.11 ± 0.02 min(-1)); and (iii) FdmV also catalyzes the amidation of FDM M-3, a structural analog of FDM C, to afford amide FDM M-6 in vitro, albeit at significantly reduced efficiency. Preliminary enzymatic studies revealed that, in addition to the common nitrogen sources (L-Gln and free amine) of class II glutamine amidotransferases (to which AS B belongs), FdmV can also utilize L-Asn as a nitrogen donor. The amide bond formation in FDM A biosynthesis is proposed to occur after C-8 hydroxylation but before the carbaspirocycle formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926388      PMCID: PMC2998092          DOI: 10.1074/jbc.M110.147744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Fredericamycin B and C from Streptomyces griseus: structure elucidation after 23 years.

Authors:  Bernd Sontag; Johannes G Müller; Friedrich G Hansske
Journal:  J Antibiot (Tokyo)       Date:  2004-12       Impact factor: 2.649

2.  Recombinant polyketide synthesis in Streptomyces: engineering of improved host strains.

Authors:  R Ziermann; M C Betlach
Journal:  Biotechniques       Date:  1999-01       Impact factor: 1.993

Review 3.  Mechanistic issues in asparagine synthetase catalysis.

Authors:  N G Richards; S M Schuster
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1998

Review 4.  The amidotransferases.

Authors:  H Zalkin
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1993

5.  Structure of fredericamycin A, an antitumor antibiotic of a novel skeletal type; spectroscopic and mass spectral characterization.

Authors:  R Misra; R C Pandey; B D Hilton; P P Roller; J V Silverton
Journal:  J Antibiot (Tokyo)       Date:  1987-06       Impact factor: 2.649

6.  Pradimicins A, B and C: new antifungal antibiotics. I. Taxonomy, production, isolation and physico-chemical properties.

Authors:  K Tomita; M Nishio; K Saitoh; H Yamamoto; Y Hoshino; H Ohkuma; M Konishi; T Miyaki; T Oki
Journal:  J Antibiot (Tokyo)       Date:  1990-07       Impact factor: 2.649

7.  Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius.

Authors:  K Madduri; J Kennedy; G Rivola; A Inventi-Solari; S Filippini; G Zanuso; A L Colombo; K M Gewain; J L Occi; D J MacNeil; C R Hutchinson
Journal:  Nat Biotechnol       Date:  1998-01       Impact factor: 54.908

8.  Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector.

Authors:  D J MacNeil; K M Gewain; C L Ruby; G Dezeny; P H Gibbons; T MacNeil
Journal:  Gene       Date:  1992-02-01       Impact factor: 3.688

9.  Fredericamycin A, a new antitumor antibiotic. I. Production, isolation and physicochemical properties.

Authors:  R C Pandey; M W Toussaint; R M Stroshane; C C Kalita; A A Aszalos; A L Garretson; T T Wei; K M Byrne; R F Geoghegan; R J White
Journal:  J Antibiot (Tokyo)       Date:  1981-11       Impact factor: 2.649

10.  Identification and cloning of the gene involved in the final step of chlortetracycline biosynthesis in Streptomyces aureofaciens.

Authors:  Tetsuo Nakano; Koichiro Miyake; Hirofumi Endo; Tohru Dairi; Toru Mizukami; Ryoichi Katsumata
Journal:  Biosci Biotechnol Biochem       Date:  2004-06       Impact factor: 2.043

View more
  5 in total

1.  Characterization of the amicetin biosynthesis gene cluster from Streptomyces vinaceusdrappus NRRL 2363 implicates two alternative strategies for amide bond formation.

Authors:  Gaiyun Zhang; Haibo Zhang; Sumei Li; Ji Xiao; Guangtao Zhang; Yiguang Zhu; Siwen Niu; Jianhua Ju; Changsheng Zhang
Journal:  Appl Environ Microbiol       Date:  2012-01-20       Impact factor: 4.792

2.  Enzymatic C-H Oxidation-Amidation Cascade in the Production of Natural and Unnatural Thiotetronate Antibiotics with Potentiated Bioactivity.

Authors:  Jie Li; Xiaoyu Tang; Takayoshi Awakawa; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2017-09-01       Impact factor: 15.336

3.  Analysis and refactoring of the A-74528 biosynthetic pathway.

Authors:  Jay T Fitzgerald; Louise K Charkoudian; Katharine R Watts; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2013-03-04       Impact factor: 15.419

4.  Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus.

Authors:  Torben Hofeditz; Claudia Eva-Maria Unsin; Jutta Wiese; Johannes F Imhoff; Wolfgang Wohlleben; Stephanie Grond; Tilmann Weber
Journal:  Antibiotics (Basel)       Date:  2018-06-28

5.  Characterization of the xiamenmycin biosynthesis gene cluster in Streptomyces xiamenensis 318.

Authors:  Yong Yang; Ling Fu; Jinlong Zhang; Linghan Hu; Minjuan Xu; Jun Xu
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.